デフォルト表紙
市場調査レポート
商品コード
1433401

瞳孔計の世界市場:2023-2030年

Global Pupillometer Market 2023-2030

出版日: | 発行: Orion Market Research | ページ情報: 英文 200 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.88円
瞳孔計の世界市場:2023-2030年
出版日: 2023年12月20日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の瞳孔計市場は予測期間(2023-2030年)にCAGR 6.9%で成長すると予測されます。市場の成長は、世界中のヘルスケアにおける需要の増加に起因しています。ヘルスケアでは、特に眼科、神経科、クリティカルケアなどの分野で、信頼性が高く効率的な診断ツールへの需要が高まっています。瞳孔計は、神経疾患、脳外傷の診断、重篤な患者のモニタリングに不可欠です。例えば、2020年8月、トプコンヘルスケアは新製品Aladdin-Mを発表しました。Aladdin-Mは角膜トポグラフィー、瞳孔計測、光学生体計測を統合し、角膜曲率、瞳孔動態、軸長メトリクスを確実に評価します。

セグメント別の展望

神経学サブセグメントが瞳孔計の世界市場でかなりのシェアを占めると予測される

アプリケーションの中で、神経学サブセグメントが世界の瞳孔計市場でかなりのシェアを占めると予想されています。このセグメントの成長は、神経疾患の増加に起因しています。神経疾患や外傷性脳損傷の有病率の上昇は、迅速な検査や治療を実行するために瞳孔計のような正確な診断機器の活用を必要としています。NeurOpticsは2021年2月、瞳孔計教育シンポジウムのプラットフォームを立ち上げました。このプラットフォームでは、神経障害のリスクがある患者の評価とスクリーニングにおいて瞳孔計と神経学的瞳孔指数(NPi)が果たす重要な役割を実証する、製品と臨床の両方に焦点を当てたプレゼンテーションのシリーズが含まれます。

地域別展望

世界の瞳孔計市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されています。中でも、アジア太平洋地域は、様々なウェブサイトやベンダーを通じて瞳孔計の入手可能性が高まっていることから、世界市場で突出したシェアを占めると予測されており、市場拡大の原動力となると予測されています。

北米地域は瞳孔計の世界市場において著しいCAGRで成長すると予測される

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。地域の成長は、地域全体の臨床需要の増加に起因しています。X線検査指標と神経疾患との間の潜在的な関連性を明らかにするデータは、正確な診断方法の重要性を強調しています。瞳孔反応性を独立して定量化できる瞳孔計は、IPHや虚血性脳卒中などの疾患の神経学的検査でますます有用性を増しています。2022年12月の国立医薬品食品衛生研究所(gov.)によると、74枚のCT画像を有する53人の患者のうち、調査によるところ、49.1%が女性で、年齢の中央値は67歳でした。IPH患者は虚血性脳卒中患者に比べてMLS-SPとPGSが大きく、それぞれ6.2mm対4.0mm、5.6mm対3.4mmでした。この研究では、瞳孔反応性とX線シフトマーカーとの間に有意な関連は認められなかったが、IPHと虚血性脳卒中のコホートでは、MLS-SPとDiff NPiとの間に潜在的な関連が認められました。このことから、正中線シフトと瞳孔反応性の非対称性との関連は、IPHと虚血性脳卒中とで異なることが示唆され、さらなる前向き研究の必要性が強調されました。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Dragerwerk AG & Co. KGaA
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Essilor Ltd.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Haag-Streit AG
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 瞳孔計の世界市場:タイプ別
    • デジタル
    • ビデオ
  • 瞳孔計の世界市場:用途別
    • 眼科
    • 神経学
    • 腫瘍学
    • その他(麻酔科、クリティカルケア、外傷・救急医療)
  • 瞳孔計の世界市場:エンドユーザー別
    • 病院
    • 眼科クリニック
    • その他(調査機関および大学、製薬会社および臨床研究機関(CROs))

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Good-Lite Company
  • HAMAMATSU Group
  • HEINE Optotechnik GmbH & Co. KG
  • Johnson & Johnson Vision Care, Inc.
  • KARL STORZ,
  • Konan Medical USA Inc.
  • NeurOptics Inc.
  • NIDEK CO., LTD.
  • Procyon TechSolutions
  • Reichert Inc.
  • SCHWIND eye-tech-solutions GmbH
  • Takagi Ophthalmic Instruments Europe Ltd.
  • US Ophthalmic.
  • VISIONIX USA INC.
図表

LIST OF TABLES

  • 1. GLOBAL PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY TYPE , 2022-2030 ($ MILLION)
  • 2. GLOBAL DIGITAL PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL VIDEO PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL PUPILLOMETER IN OPHTHALMOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL PUPILLOMETER IN NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL PUPILLOMETER IN NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL PUPILLOMETER IN NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 10. GLOBAL PUPILLOMETER FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PUPILLOMETER FOR EYE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL PUPILLOMETER FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 18. EUROPEAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. EUROPEAN PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD PUPILLOMETER MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PUPILLOMETER MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL DIGITAL PUPILLOMETER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL VIDEO CONSENT PUPILLOMETER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PUPILLOMETER MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL PUPILLOMETER IN OPHTHALMOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL PUPILLOMETER IN NEUROLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL PUPILLOMETER IN ONCOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL PUPILLOMETER IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL PUPILLOMETER MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 10. GLOBAL PUPILLOMETER FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL PUPILLOMETER FOR EYE CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL PUPILLOMETER FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL PUPILLOMETER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD PUPILLOMETER MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027991

Global Pupillometer Market Size, Share & Trends Analysis Report by Type (Digital, and Video), by Application (Ophthalmology, Neurology, Oncology, and Others) and by End User (Hospitals, Eye Clinics, and Others), Forecast Period (2023-2030)

The global pupillometer market is anticipated to grow at a CAGR of 6.9% during the forecast period (2023-2030). The market's growth is attributed to the growing demand in healthcare across the globe. In healthcare, it contains an increasing demand for reliable and efficient diagnostic tools, particularly in sectors such as ophthalmology, neurology, and critical care. The pupillometers are essential in diagnosing neurological diseases, brain traumas, and monitoring patients in critical care situations. For instance, in Augut 2020, Topcon Healthcare launched its new Aladdin-M instrument. Aladdin-M integrates corneal topography, pupillometry, and optical biometry to assess corneal curvature, pupil dynamics, and axial length metrics reliably.

Segmental Outlook

The global pupillometer market is segmented on the type, application, and end user. Based on the type, the market is sub-segmented into digital, and video. Based on the application, the market is sub-segmented into ophthalmology, neurology, oncology, and others. Furthermore, on the basis of end user, the market is sub-segmented into hospitals, eye clinics, and others. The ophthalmology subcategory is expected to capture a significant portion of the market share within the application segment. The growth can be attributed to the demand for precision in eye surgeries is driven by the requirement for accurate measurements and meticulous planning in refractive surgeries and cataract procedures. This has led to an increased interest in systems such as, SeeNa, that aid surgeons in achieving the optimal surgical outcomes possible. For instance, in October 2023, Bausch + Lomb Corp. launched the SeeNa optical biometry and topography system for refractive cataract patients.

The Neurology Sub-Segment is Anticipated to Hold a Considerable Share of the global Pupillometer Market

Among the application, the neurology sub-segment is expected to hold a considerable share of the global Pupillometer market. The segmental growth is attributed to the increasing neurological disorders. The rising prevalence of neurological conditions and traumatic brain injuries needs for the utilization of precise diagnostic equipment such as pupillometers to perform prompt examinations and therapies. For instane, in February 2021, NeurOptics launched Pupillometry Education Symposiums platform, that includes a series of both product and clinical-focused presentations that demonstrate the essential role pupillometry and the neurological pupil index (NPi) play in the assessment and screening of patients at risk of neurological injury.

Regional Outlook

The global pupillometer market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing availability of pupillometers in the region via a range of websites and vendors is projected to drive market expansion.

The North America Region is Expected to Grow at a Significant CAGR in the global Pupillometer Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing clinical demand across the region. The data revealing potential associations between radiographic indicators and neurological disorders underscore the importance of precise diagnosis methods. Pupillometers, that can independently quantify pupil responsiveness, have been increasingly useful in neurological examinations for disorders such as IPH and ischemic stroke. According to the National Institute of health (gov.) in December 2022, as per the study among the 53 patients with 74 CT images, 49.1% were female, with a median age of 67 years. The patients with IPH showed greater MLS-SP and PGS compared to patients with ischemic stroke, with measurements of 6.2 mm versus 4.0 mm and 5.6 mm versus 3.4 mm, respectively. The study found no significant association between pupil reactivity and radiographic shift markers, but potential relationships were found between MLS-SP and Diff NPi in the IPH and ischemic stroke cohorts. This suggests that the connection between midline shift and asymmetric pupil reactivity varies between IPH and ischemic stroke, emphasizing the need for additional prospective research.

Market Players Outlook

The major companies serving the pupillometer market includes HAMAMATSU Group, HEINE Optotechnik GmbH & Co. KG, Johnson & Johnson Vision Care, Inc., KARL STORZ, Konan Medical USA Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021,NeurOptics, launched NPi-300 Pupillometer in the US. The NPi-300 Pupillometer is a versatile tool for neurological examination in both adults and pediatric patients, covering a wide range of diagnoses such as traumatic brain injury, stroke, seizure, and other medical conditions.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global pupillometer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Dragerwerk AG & Co. KGaA
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Essilor Ltd.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Haag-Streit AG
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Pupillometer Market by Type
    • 4.1.1. Digital
    • 4.1.2. Video
  • 4.2. Global Pupillometer Market by Application
    • 4.2.1. Ophthalmology
    • 4.2.2. Neurology
    • 4.2.3. Oncology
    • 4.2.4. Others (Anesthesiology and Critical Care, and Trauma and Emergency Medicine)
  • 4.3. Global Pupillometer Market by End User
    • 4.3.1. Hospitals
    • 4.3.2. Eye Clinics
    • 4.3.3. Others (Research Institutions and Universities, and Pharmaceutical Companies and Clinical Research Organizations (CROs))

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Good-Lite Company
  • 6.2. HAMAMATSU Group
  • 6.3. HEINE Optotechnik GmbH & Co. KG
  • 6.4. Johnson & Johnson Vision Care, Inc.
  • 6.5. KARL STORZ,
  • 6.6. Konan Medical USA Inc.
  • 6.7. NeurOptics Inc.
  • 6.8. NIDEK CO., LTD.
  • 6.9. Procyon TechSolutions
  • 6.10. Reichert Inc.
  • 6.11. SCHWIND eye-tech-solutions GmbH
  • 6.12. Takagi Ophthalmic Instruments Europe Ltd.
  • 6.13. US Ophthalmic.
  • 6.14. VISIONIX USA INC.